login
login

Europe Daily Bulletin No. 13001

28 July 2022
Contents Publication in full By article 22 / 22
NEWS BRIEFS / Health
EMA examines two vaccines from PfizerBioNTech and Moderna adapted to new variant of concern

27/07/2022 (Agence Europe)On 22 July, the European Medicines Agency (EMA) initiated an evaluation of two SARS-CoV-2 vaccines adapted to a new variant of concern. The evaluation concerns the adapted forms of two mRNA vaccines that already have a conditional marketing authorisation: the Comirnaty vaccine developed by the Pfizer-BioNTech companies and the Spikevax vaccine developed by the Moderna company. The two companies have each proposed a bivalent mRNA vaccine tailored to the...

Contents

BEACONS
Russian invasion of Ukraine
COURT OF JUSTICE OF THE EU
SECTORAL POLICIES
EXTERNAL ACTION
EDUCATION - YOUTH
ECONOMY - FINANCE - BUSINESS
NEWS BRIEFS